Finance Monthly M&A Awards 2019 - Winners Edition

22 Financial Advisers to Takeda Financial Advisers to Shire TAKEDA ACQUIRE SHIRE FOR $69BN JAPAN MERGERS & ACQUISITIONS Pharmaceutical INTRODUCTION Takeda announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D- driven biopharmaceutical leader headquartered in Japan. Banks, law firms and other advisers stand to earn up to $963M (£749.3M) in fees from Takeda Pharmaceutical’s (4502.T) $62BN (£48.3BN) takeover of drugmaker Shire SHP.L, according to documents for the deal. DEAL OF THE YEAR 2019